Gretchen M. Oakley
University of Utah
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Gretchen M. Oakley.
International Forum of Allergy & Rhinology | 2016
Gretchen M. Oakley; Jeremiah A. Alt; Rodney J. Schlosser; Richard J. Harvey; Richard R. Orlandi
Diagnostic strategies employed for cases of cerebrospinal fluid (CSF) rhinorrhea vary widely due to limited evidence‐based guidance.
International Forum of Allergy & Rhinology | 2015
Gretchen M. Oakley; Karen Curtin; Quinn Orb; Carole Schaefer; Richard R. Orlandi; Jeremiah A. Alt
Chronic rhinosinusitis (CRS) is a highly prevalent inflammatory condition, with significant effects on morbidity and quality of life, yet little is known about its pathogenesis. Preliminary evidence suggests there is a heritable component to the multifactorial etiology of CRS; however, our understanding of this genetic susceptibility is limited.
International Forum of Allergy & Rhinology | 2017
Aneeza W. Hamizan; Jenna M. Christensen; Jareen Ebenzer; Gretchen M. Oakley; Jessica Tattersall; Raymond Sacks; Richard J. Harvey
Middle turbinate edema could be a characteristic feature of aeroallergen sensitization. In this study we sought to determine the diagnostic characteristics of middle turbinate edema as a marker of inhalant allergy.
International Forum of Allergy & Rhinology | 2016
Gretchen M. Oakley; Richard R. Orlandi; Bradford A. Woodworth; Pete S. Batra; Jeremiah A. Alt
Management strategies employed for cases of cerebrospinal fluid (CSF) rhinorrhea vary widely because of limited evidence‐based guidance.
Archives of Otolaryngology-head & Neck Surgery | 2013
Gretchen M. Oakley; Karen Curtin; Richard Pimentel; Luke O. Buchmann; Jason P. Hunt
IMPORTANCE Determining if relatives of patients diagnosed as having papillary thyroid carcinoma (PTC) are at increased risk of developing the same cancer--and if so, which relatives and to what degree--would help identify those who require closer clinical attention. This could lead to earlier cancer detection and improved prognoses. OBJECTIVE To define the familial risk of PTC using a unique population research database. DESIGN, SETTING, PARTICIPANTS Retrospective review at a tertiary care facility using the Utah Population Database, which is linked to medical records and the Utah Cancer Registry, from 1966 through 2011. The study population comprised 4460 patients diagnosed as having PTC in Utah between 1966 and 2011 and their first- through fifth-degree relatives and spouses. These patients were compared 5:1 with matched, population-based controls. MAIN OUTCOMES AND MEASURES Statistically significant increased risk of PTC in any first- through fifth-degree relatives or spouses of patients diagnosed as having this cancer. RESULTS First-, second-, and third-degree relatives of PTC probands had a significant increased risk of developing this cancer compared with population controls. First-degree relatives of probands were at a 5.4-fold increased risk (P < 10(-15)) of being diagnosed as having this cancer themselves. Second- and third-degree relatives had a 2.2-fold (P < 10(-11)) and 1.8-fold increased risk (P < 10(-8)), respectively. Siblings of probands were at highest risk (odd ratio, 6.8; P < 10(-15)). There was no significant increased risk observed in spouses of probands. CONCLUSIONS AND RELEVANCE In the largest population study to date, a high risk of PTC is confirmed in first-degree relatives. Furthermore, significant increased risk extends to second- and third-degree relatives but not to spouses of probands. Translational studies are needed to better define the genetic predisposition to familial papillary thyroid cancer and for the development and implementation of optimal screening approaches.
International Forum of Allergy & Rhinology | 2018
Richard J. Harvey; Kornkiat Snidvongs; Larry Kalish; Gretchen M. Oakley; Raymond Sacks
Persistent mucosal inflammation in patients with chronic rhinosinusitis (CRS) often results in ongoing symptoms, recurrence of polypoid mucosa, infective exacerbations, and further systemic medication despite surgical intervention. Debate exists as to the most effective topical therapy in CRS.
Laryngoscope | 2016
Quinn Orb; Karen Curtin; Gretchen M. Oakley; Jathine Wong; Jeremy D. Meier; Richard R. Orlandi; Jeremiah A. Alt
To determine the risk of chronic rhinosinusitis (CRS) in relatives of children with a diagnosis of CRS.
Otolaryngologic Clinics of North America | 2016
Gretchen M. Oakley; Henry P. Barham; Richard J. Harvey
The frontal sinus can present a challenging surgical dissection for the endoscopic surgeon. Image guidance as a surgical adjunct has become widely accepted for surgeries in this area. It can help verify vital structures and manage disorienting surgical conditions, improving surgeon confidence in performing safer and more complete surgery. It is relied upon heavily for placement of limited external frontal sinusotomies for disease beyond the endoscopic reach, and for mapping the frontal sinus for osteoplastic flap bony cuts. Its use has contributed to the expanding role of endoscopic surgical approaches for paranasal sinus inflammatory and neoplastic disease.
International Forum of Allergy & Rhinology | 2018
Jacob P. Brunner; Joshua M. Levy; Melissa L. Ada; Kiranya E. Tipirneni; Henry P. Barham; Gretchen M. Oakley; Daniel R. Cox; Bobby D. Nossaman; Edward D. McCoul
Total intravenous anesthesia (TIVA) has been proposed as a method to reduce blood loss during endoscopic sinus surgery (ESS). Impaired sinonasal visualization due to mucosal bleeding may be burdensome in cases of chronic rhinosinusitis (CRS) with high‐grade inflammatory disease, suggesting a role for TIVA in that disease subgroup.
International Forum of Allergy & Rhinology | 2018
Kristine A. Smith; Shaelene Ashby; Richard R. Orlandi; Gretchen M. Oakley; Jeremiah A. Alt
Chronic rhinosinusitis (CRS) is associated with productivity losses exceeding US